News

Stronger warnings on popular insomnia medications could have an impact on prescribing, some experts say.

While FDA approved the second biosimilar drug to Enbrel, the success of the medication hinges on a pending lawsuit. 

How to make your LinkedIn profile stand out and work for you.

Key ways healthcare executives can improve therapy compliance.

Pharmacists are in a unique position to improve orphan drug and precision medicine channels.

Experts offer their thoughts on what the specialty pharmacy industry will look like over the next year.

As the healthcare landscape continues to change at a rapid pace, drug manufacturers need to take a long, hard look at their marketing and commercialization options.

From tips for new healthcare leaders to growing initiatives, Andrea Walsh shows why people are the most important part of every part of healthcare.

At the 2019 Asembia Specialty Pharmacy Summit, Cardinal Health’s Bruce Feinberg articulates the pros and cons of copay accumulator programs.

OptumRx will expand its drug discounts to employer-sponsored health plans starting next year. Here’s what the move means for healthcare.

CDC commentary claims patients taken off opiods too soon.

A new report determines the trends fueling drug research and development over the past 10 years-and into the future.

As a healthcare executive, it’s your job to excite and inspire your leadership team to bring their A-game. Here are six powerful ways.

Patients taking heart medications are most at risk when a pharmacy shuts its doors.

The first step to tackling one of healthcare’s biggest problems is to gain more complete access to patient data.

The growing availability of direct-to-consumer genetic tests highlights the need for validating and interpreting the tests’ results.

FDA cleared the first medical device to treat attention deficit hyperactivity disorder (ADHD) in kids.

How do healthcare executives stay passionate about coming to work and keeping things positive and new? Managed Healthcare Executive asked 15 of them, and here’s what they said.

How to make Medicare Advantage plans attractive by meeting the needs of a new generation of senior patients.

Five surprising updates about one of healthcare’s top trends.

A Commonwealth Fund study has revealing findings about PBMs’ use of rebates and impact on drug prices.

How technologies are helping health systems think about-and mobilize on-social determinants of health.

Healthcare experts weigh in on what we can expect in 2019 and beyond.

The real-world strategies used to manage the high cost of specialty meds.

The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?

Metastatic breast cancer drug expands treatment to men.